NCT07686159

Brief Summary

Human Volunteer Participation: A total of six (6) healthy adult volunteers participated in the study, including three males and three females aged between 18 and 22 years. The volunteers participated in:

  • Arm-in-Cage Test Procedure
  • Dermatological Safety Test All participants were:
  • Non-tobacco users
  • Free from dermatosis or chronic skin disease
  • Free from known allergic reactions to arthropod bites or mosquito repellents
  • Informed regarding the objectives, procedures, risks, and benefits of the study Written informed consent was obtained from all volunteers before participation. Participants were instructed not to apply perfumes, aromatics, skincare products, or other mosquito repellents on the hands for at least 12 hours before and during the experiment to minimize experimental bias. Safety and Ethical Considerations:
  • All experiments were conducted under controlled laboratory conditions.
  • Appropriate safety precautions and monitoring procedures were maintained throughout the study.
  • Volunteers retained the right to withdraw from the study at any stage without penalty.
  • Confidentiality and anonymity of volunteer information were strictly maintained.
  • No severe physical or psychological risk was associated with participation.
  • Immediate medical support and first-aid facilities were available during experimentation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2025

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
Last Updated

July 7, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

June 5, 2026

Last Update Submit

July 2, 2026

Conditions

Keywords

mosquito repellentefficacy testmosquito biteprotection time

Outcome Measures

Primary Outcomes (4)

  • Number of Mosquito Landings on the Treated Forearm During the WHO Arm-in-Cage Test

    The number of mosquito landings on the treated forearm will be counted during each exposure period using the standardized WHO Arm-in-Cage Test with 50 unfed female Aedes aegypti mosquitoes.

    Measured at 0, 1, 2, 4, 6, and 8 hours after repellent application.

  • Number of Confirmed Mosquito Bites During the WHO Arm-in-Cage Test

    The number of confirmed mosquito bites occurring on the treated forearm will be recorded during each exposure period.

    Measured at 0, 1, 2, 4, 6, and 8 hours after repellent application.

  • Complete Protection Time Measured by the WHO Arm-in-Cage Test

    Complete Protection Time is defined as the elapsed time from repellent application until the first confirmed mosquito landing or bite.

    Up to 8 hours after application.

  • Percentage Protection Against Mosquito Landing

    Percentage protection will be calculated by comparing the number of mosquito landings on treated skin with the corresponding control observations.

    Measured at 0, 1, 2, 4, 6, and 8 hours after application

Secondary Outcomes (1)

  • Number of Participants With Treatment-Related Skin Reactions

    Within 8 hours after application.

Study Arms (1)

Arm-in-Cage Test Procedure

EXPERIMENTAL

This arm evaluates the efficacy of commercially available skin-applied mosquito repellent formulations against Aedes albopictus females using a standardized WHO-recommended Arm-in-Cage Test (ACT). The study assesses mosquito landing/biting protection under controlled laboratory conditions using human volunteers and standardized exposure procedures.

Device: Mosquito Repellent Products (Topical and Spatial Formulations)

Interventions

Specialized rubber gloves designed to expose only a 4 × 4 cm area of dorsal hand skin while protecting the rest of the hand. Gloves were replaced between trials to prevent cross-contamination or residual repellent effects.

Arm-in-Cage Test Procedure

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • healthy adult volunteers participated

You may not qualify if:

  • Sick and children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biomedical Engineering Department, Military Institute of Science and Technology

Dhaka, Dhaka Division, 1216, Bangladesh

Location

Related Publications (1)

  • Yoon JK, Kim KC, Cho Y, Gwon YD, Cho HS, Heo Y, Park K, Lee YW, Kim M, Oh YK, Kim YB. Comparison of Repellency Effect of Mosquito Repellents for DEET, Citronella, and Fennel Oil. J Parasitol Res. 2015;2015:361021. doi: 10.1155/2015/361021. Epub 2015 Oct 7.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
This study was conducted as an open-label evaluation of commercially available mosquito repellent products. Neither the participants nor the investigators were blinded to the identity of the tested products because the formulations (coils, vaporizers, sprays, creams, and natural repellents) differed substantially in appearance, mode of application, and operation. Outcome measurements included repellency efficacy, protection duration, dermatological safety, and user-reported observations.
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Six healthy adult volunteers (three males and three females, aged 18-22 years) participated in the study. All volunteers underwent the Arm-in-Cage repellency bioassay and dermatological safety testing. Each participant was exposed to multiple commercially available mosquito repellent products according to the study protocol, allowing comparative assessment of efficacy, protection duration, and skin safety. No separate participant groups were established; therefore, all participants belonged to a single study arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 5, 2026

First Posted

July 7, 2026

Study Start

September 25, 2025

Primary Completion

October 25, 2025

Study Completion

November 5, 2025

Last Updated

July 7, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations